EUVIMEDEUVIMED entdecken
Crossref

Moving away from chemotherapy in newly diagnosed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia

Fadi G Haddad iD, Hampig Raphael Kourie, Khalil Saleh

British Journal of Haematology · 2023

DOI: 10.1111/bjh.19012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Fadi G Haddad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Philadelphia Chromosome, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy‐free regimens are reshaping the treatment landscape of Philadelphia chromosome‐positive acute lymphoblastic leukaemia. The report by Xie et al. suggests that the combination of dasatinib and prednisone is effective as induction and early consolidation. Survival was improved in patients who subsequently underwent allogeneic stem cell transplantation. Commentary on: Xie et al. Dasatinib plus prednisone as induction and consolidation for adults with Ph‐positive acute lymphoblastic leukaemia: A single‐arm, multicentre, phase 2 trial. Br J Haematol 2023;202:1119–1126.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Philadelphia ChromosomePrecursor Cell Lymphoblastic Leukemia-LymphomaAdultHumansDasatinibPrednisoneAntineoplastic Combined Chemotherapy ProtocolsProtein Kinase Inhibitors

Stichwörter der Autor:innen

blinatumomabchemotherapyponatinibsteroidstyrosine kinase inhibitor

Substanzen

DasatinibPrednisoneProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Hematology and Oncology, Saint Joseph University, Beirut, Lebanon.
  • Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France.

ORCID-Profile: Fadi G Haddad

Zitieren

APA

Haddad, F. G., Kourie, H. R., & Saleh, K. (2023). Moving away from chemotherapy in newly diagnosed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.19012

Vancouver

Haddad FG, Kourie HR, Saleh K. Moving away from chemotherapy in newly diagnosed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 2023. doi:10.1111/bjh.19012

BibTeX
@article{Haddad2023,
  author = {Haddad, Fadi G and Kourie, Hampig Raphael and Saleh, Khalil},
  title = {Moving away from chemotherapy in newly diagnosed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.19012}
}
Kostenlos starten →